Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pulmonary Medicine

Bloomberg News reports that the FDA has approved the drug Adempas, produced by Bayer AG, for the treatment of pulmonary hypertension. The drug is “the first to treat the form of the condition that lasts six months or longer often caused by a blood...

Reuters Health • The Doctor's Channel Daily Newscast

Radiation Monotherapy Improves Survival in Elderly NSCLC Patients

NEW YORK (Reuters Health) – Elderly patients with unresected stage III non-small-cell lung cancer (NSCLC) who are not candidates for chemoradiotherapy benefit from radiation therapy (RT) alone, according to a population-based study. “We found that RT...
Post-operative venous thromboembolisms (VTE) are often used as a metric to determine hospital quality, but a new study in JAMA has found that this may be a poor measure, Reuters reports. The study looked at 2,786 hospitals, deemed either high quality...